Single Cell Analysis Reveals Immune Dysfunction from the Earliest Stages of CLL that can be Reversed by Ibrutinib

dbGaP Study Accession: phs002705.v1.p1

Study
phs002705.v1.p1

Variable Name and Accession: Variable Name: AGE_ONSET
Variable Accession: phv00495861.v1.p1
Variable belongs to dataset: pht011841.v1.p1 : CLL_Reversal_Ibrutinib_Subject_Phenotypes: This subject phenotypes data table includes age of disease onset.
Variable Description: Disease onset age
Statistical Summary